Incyte Corporation (INCY) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Incyte Corporation  (NASDAQ: INCY)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Incyte's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Incyte's ROI in the third quarter of 2026?
Incyte Corporation achieved a return on average invested assets (ROI) of 6.81 % in its third quarter of 2026, this is above INCY's average return on investment of -2.53%.
Incyte Corporations investments during the 12 months ending in the third quarter of 2026 are valued at $5 billion

ROI decreased relative to the period ending Jun 30 2026, due to the decline in net income.

Within the Healthcare sector 70 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2026 quarter, so far to 187, from total ROI ranking in the second quarter of 2026 at 220.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 36.49 % 43.81 % 42 % 16.05 % -4.14 %
Y / Y Net Income Change TTM -66.06 % 85.15 % 207.33 % 318.19 % 1016.5 %
Investment (TTM) in Millions 5,849 6,561 5,849 5,443 4,992
Return On Investment (TTM) 6.81 % 28.23 % 27.5 % 27.08 % 27.38 %
INCY's Overall Ranking # 187 # 220 # 205 # 261 # 2388
Seq. Investment Change TTM 3.76 % 9.69 % 9.58 % 9.45 % 9.32 %
Seq. Net Income Change TTM -74.98 % 12.61 % 11.28 % 8.25 % 36.48 %
Net Income (TTM) in Millions 403 1,612 1,432 1,287 1,189

INCY Company Profile >> Back to INCY Roi Comparisons >> See Annual INCY Return On Investment



Return On Investment INCY's Ranking
Within: No.
Industry # 5
Sector # 71
Overall # 187

Return On Investment Statistics
High Average Low
28.23 %
-2.53 %
-91.22 %
(Jun 30 2026)   (Mar 31 2012)







Financial Statements
Incyte's III. Quarter Investments $ 5,849 Millions INCY's Balance sheet
Incyte's III. Quarter Income $ -785 Millions Quarterly INCY's Income Statement
INCY's Income by Division See INCY's Income by Division


INCY Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 5,443 3,802 5,542 4,684 4,047
Y / Y Investment Growth 43.14 % -31.38 % 18.31 % 15.73 % 39.7 %
Net Income in Millions 1,287 33 598 341 949
Y / Y Net Income Growth 3844.96 % -94.54 % 75.42 % -64.09 % -
Annual Return On Investment 23.64 % 0.86 % 10.78 % 7.27 % 23.44 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 23.64 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
INCY's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for INCY's Competitors
Subscribers only: Roi for Incyte's Suppliers
Subscribers only: Return On Investment for INCY's Customers

Other Ratios
INCY's Roa INCY's Inventory Turnover Ratio INCY's Growth Rates INCY's Dividend Statistics
INCY's Profitability Ratios INCY's Asset Turnover Ratio INCY's Dividend Growth
INCY's Roe INCY's Valuation Ratios INCY's Financial Strength Ratios INCY's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Denali Therapeutics Inc   17.88 %
West Pharmaceutical Services Inc   17.65 %
Healthcare Services Group Inc   17.18 %
Neurocrine Biosciences Inc   16.94 %
Krystal Biotech Inc   16.91 %
Vertex Pharmaceuticals Inc  16.63 %
Sanuwave Health Inc   16.50 %
Intuitive Surgical Inc   16.30 %
Hca Healthcare Inc   15.54 %
Kiniksa Pharmaceuticals International Plc  15.45 %
Amgen Inc   13.64 %
Carlisle Companies Incorporated  13.64 %
Bristol myers Squibb Company  13.59 %
3m Company  13.24 %
Alpha Pro Tech Ltd   13.18 %
Beone Medicines Ltd   13.17 %
Regeneron Pharmaceuticals Inc   13.00 %
Abbvie Inc   12.87 %
Lantheus Holdings Inc   11.96 %
Msa Safety Inc  11.78 %
Inspire Medical Systems inc   11.63 %
Transmedics Group Inc   11.55 %
Bioventus Inc   11.26 %
Tenet Healthcare Corp  10.91 %
Bio rad Laboratories Inc   10.59 %
Lemaitre Vascular Inc   10.56 %
Johnson and Johnson  10.53 %
Encompass Health Corporation  10.41 %
Ani Pharmaceuticals Inc  9.61 %
Tactile Systems Technology Inc   9.27 %

Date modified: 2026-10-30T16:59:18+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.